How Have Psychedelics Been Used to Help Terminally Ill Patients With Death Anxiety?

Psychedelics administered in controlled and therapeutic settings have, in many cases, alleviated anxiety surrounding death, increased feelings of connectedness, increased ratings of death acceptance, and induced mystical or spiritually significant experiences for individuals at the end of life. While substances such as psilocybin, which is the active ingredient in “magic mushrooms” and other psychedelic drugs, are currently being studied in clinical trials for the treatment of psychiatric disorders and chronic diseases, their potential use in end-of-life settings is not yet fully realized. 

Researchers believe that taking psychedelics provides terminally ill patients with a sense of peace and acceptance regarding the inevitability of their death. This may occur through confronting their fears, new insights into their understanding of their mortality, or an existential or spiritual experience that may help them find meaning or purpose through a new perspective. MDMA-assisted therapy has similar benefits in reducing anxiety and fear, promoting emotional resilience, gaining a sense of reconnection to life, and improving quality of life.

Although there are many promising findings surrounding the use of psychedelics among terminally ill patients, the emergence of psychedelic medicine is in its early stages, with active development resulting from ongoing research and clinical trials. Research is necessary to fully understand the potential efficacy, long-term effects, and safety of the use of psychedelic substances in individuals with life-threatening or end-stage diseases. Additionally, many regulatory and legal barriers limit the more widespread compassionate use of psychedelic-assisted therapy across patient populations. Despite these challenges, the potential benefits of using psychedelics to relieve death anxiety are slowly gaining increased interest and support among patients, researchers, and healthcare professionals. 

Sources

“Psychedelics May Lessen Fear of Death and Dying, Similar to Feelings Reported by Those Who’ve Had Near-Death Experiences”. Johns Hopkins Medicine. https://www.hopkinsmedicine.org/news/newsroom/news-releases/2022/08/psychedelics-may-lessen-fear-of-death-and-dying-similar-to-feelings-reported-by-those-whove-had-near-death-experiences 

“Facing death, returning to life: A qualitative analysis of MDMA-assisted therapy for anxiety associated with life-threatening illness”. National Library of Medicine. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552520/

“Dying Patients Are Fighting for Access to Psychedelics”. Time. https://time.com/6208079/psychedelics-psilocybin-access-end-of-life/